Authors
Latest:
Ocrelizumab Wearing-Off Phenomenon: Prevalence, Predictors, and Outcomes After InterventionNearly 25% of people with multiple sclerosis in our study reported wearing off prior to their next ocrelizumab infusion while on the standard 6-month dosing interval.
Latest:
“There’s No Magic Pill”: A Multimethods Qualitative Study Exploring Routine Fatigue Care in People With Multiple SclerosisWalking while directing attention to other cognitively demanding tasks can negatively impact gait stability in people with multiple sclerosis.
Latest:
Domain-Specific Cognitive Associations With Standing Balance in Multiple SclerosisCognitive and psychological factors may contribute to balance performance and could be considered when interpreting fall risk in clinical assessments.
Latest:
Managing Cognitive Dysfunction in Multiple Sclerosis: A Snapshot of Changes in Screening, Assessment, and Treatment PracticesReferrals for cognitive remediation have also increased, and fewer providers are recommending cognition-related medications, which is consistent with the evidence in the literature on efficacies of these treatments.
Latest:
Recruitment of African American Adults With Multiple Sclerosis Into Randomized Controlled Trials of Exercise Training: Lessons Learned From Project TEAAMSThis paper describes participant outreach and recruitment strategies for an ongoing, remotely delivered, culturally tailored exercise training program for African American individuals with multiple sclerosis.
Latest:
Comparing Preferences of Men and Women With Multiple Sclerosis for Neurologist-Provided SupportEvaluate individual support preferences whenever possible, recognizing that needs vary among people with multiple sclerosis. When detailed assessment is not feasible, support provision may emphasize clear, evidence-based informational guidance for men and a broader spectrum, including informational, emotional, and esteem support, for women.